Results 211 to 220 of about 7,503,171 (257)

Temporal Interference Stimulation of Centromedian‐Parafascicular Complex in Disorders of Consciousness: A Pilot Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Treatment of disorders of consciousness (DoC) remains a major clinical challenge, and noninvasive, targeted modulation of deep brain structures has emerged as a promising therapeutic strategy. We aimed to evaluate the feasibility/safety and preliminary effects of thalamic temporal interference stimulation (TIS) targeting centromedian‐
Gengyao Hu, Changgeng Song, Dianwei Wu, Xiaoqian Niu, Jianmin Hao, Lijuan Liu, Xiaogang Kang, Wen Jiang   +7 more
wiley   +1 more source

Factors influencing Systemic Coronary Risk Estimation 2 (SCORE2). [PDF]

Cardiol J
Gryglewska-Wawrzak K, Banach M, Sakowicz A, Sosnowska B, Adach W, Bielecka-Dabrowa A.   +5 more
europepmc   +1 more source

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali, Waqar Ahmed Cheema, Fiza Nisar, Muhammad Shamoon, Sameen Sarfaraz, Ahmad Butt, Muhammad Abdullah Ali, Armaghana Abdullah, Muhammad Asad Shabbir, Muhammad Talha, Hammad Azam, Aimen Anwaar Pannun, Usama Saleem, Anousha Tanveer, Mukesh Sharma   +14 more
wiley   +1 more source

Preoperative kidney tumor risk estimation with AI: From logistic regression to transformer. [PDF]

PLoS One
Barros V, Abdallah N, Ozery-Flato M, Dekel A, Raboh M, Heller N, Rabinovici-Cohen S, Golts A, Gentili A, Lang D, Chaudhary S, Satish V, Tejpaul R, Eggel I, Guez I, Barkan E, Müller H, Hexter E, Rosen-Zvi M, Weight C.   +19 more
europepmc   +1 more source

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian, Minghui Zhao, Yuanbo Hu, Kaiyue Wang, Haiguang Liu, Zetong Bai, Kebin Zheng   +6 more
wiley   +1 more source

Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study. [PDF]

Transfusion
de Winter DP, de Haas M, Hulzebos CV, Lukens MV, Prins SA, Been JV, d'Haens EJ, Vijlbrief DC, Vrancken SLAG, Trompenaars AMP, Ceelie H, van Zogchel LMJ, Joosen AMCP, Meijssen CB, van Hillegersberg JLAM, Zant JC, van Rossem MC, van Beek R, Stas HG, Counsilman CE, Knol FR, Schiering IAM, Dubbink-Verheij GH, Verweij EJT, Lopriore E, WISE investigators.   +25 more
europepmc   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes   +4 more
wiley   +1 more source

Integrating Pathogenic Variants, Polygenic Risk Score, and Family History for Prostate Cancer Risk Estimation in Men of African Ancestry. [PDF]

Eur Urol
Chen F, Sheng X, Wang A, Xu Y, Hughley R, Xiong W, Pooler L, Wan P, Gundell SM, Kigozi G, Nakigozi G, Nalugoda F, Kagaayi J, Kigozi GN, Mugamba S, Kyasanku E, Nkale J, Olwa VO, Lubwama A, Daama A, Nakajugo R, Adusei B, Jalloh M, Gueye SM, Adjei AA, Mensah J, Fernandez PW, Adebiyi AO, Olufemi Ogunbiyi J, Aisuodionoe-Shadrach OI, Petersen L, Chen WC, McBride J, Bensen JT, Mohler JL, Taylor JA, Andrews C, Kigongo M, Colline A, Kiddu V, Namugambe J, Owamaani S, Job K, Masaba BJ, Asiimwe F, Muwanga P, Namulondo J, Nagawa F, Kayiraba C, Ogwang M, Okidi R, Oweka D, Kitara E, Obonyo J, Lajul D, Matovu P, Muheki PA, Natumanya J, Agaba E, Aculokin E, Twongyeirwe A, Mutema G, Bitamazire D, Butler EN, Ingles SA, Rybicki BA, Stanford JL, Zheng W, Berndt SI, Chanock SJ, Huff CD, Lachance J, Multigner L, Darst BF, Rebbeck TR, Brureau L, Watya S, Conti DV, Haiman CA.   +78 more
europepmc   +1 more source

Progressive Parkinsonism in PPP2R5D‐Related Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT PPP2R5D‐related neurodevelopmental disorder (Houge–Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease‐modifying
Katerina Bernardi, Enrique Gonzalez Saez‐Diez, Joshua Rong, Beril Ay, Shabbir Merchant, Kathryn Yang, Darius Ebrahimi‐Fakhari   +6 more
wiley   +1 more source

Foundation model of electronic medical records for adaptive risk estimation. [PDF]

Gigascience
Renc P, Grzeszczyk MK, Oufattole N, Goode D, Jia Y, Bieganski S, McDermott MBA, Was J, Samir AE, Cunningham JW, Bates DW, Sitek A.   +11 more
europepmc   +1 more source